about
Medical treatments for autoimmune hepatitisAuto immune hepatitisAutoimmune hepatitis in childhood: the role of genetic and immune factorsAmeliorated ConA-induced hepatitis in the absence of PKC-thetaDiagnosis, management, and treatment of hepatitis C: an updateIndications of Liver Biopsy in the Era of Noninvasive Assessment of Liver FibrosisSuccessful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature.Immune disease expressed in liver and platelets in an adolescent: a case report.Romiplostim in the management of thrombocytopenia in a patient with autoimmune hepatitis.Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment.Validation of coding algorithms for the identification of patients with primary biliary cirrhosis using administrative dataLong-term treatment outcomes for autoimmune hepatitis in Korea.HLA DRB1 Alleles Discriminate the Manifestation of Autoimmune Hepatitis as Type 1 or Type 2 in North Indian Population.Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells.Difficult treatment decisions in autoimmune hepatitis.Clinical characteristics and corticosteroid therapy in patients with autoimmune-hepatitis-induced liver failure.Autoantibodies and liver disease: uses and abuses.Diagnostic criteria for autoimmune chronic pancreatitis revisited.Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiolInterleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression.An overlap syndrome involving autoimmune hepatitis and systemic lupus erythematosus in childhood.Treatment of autoimmune hepatitis: a review of current and evolving therapies.Rare incidence of methotrexate-specific lesions in liver biopsy of patients with arthritis and elevated liver enzymesClinical features and outcome of multiple primary malignancies involving hepatocellular carcinoma: a long-term follow-up studyReview article: autoimmune hepatitis -- current management and challenges.Current status of therapy in autoimmune liver diseaseAutoimmune hepatitis: Single-center experience of clinical presentation, response to treatment and prognosis in Saudi Arabia.PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC).Azathioprine metabolite measurements are not useful in following treatment of autoimmune hepatitis in Alaska Native and other non-Caucasian people.Acute liver injury in two workers exposed to chloroform in cleanrooms: a case report.Liver transplantation and autoimmune hepatitis.Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen/liver pancreas in autoimmune hepatitis.Autoimmune liver disease - are there spectra that we do not know?Unnecessary repeat requesting of tests: an audit in a government hospital immunology laboratoryPrevalence of Celiac Disease in Children with Autoimmune Hepatitis and vice versa.Immune mechanisms of Concanavalin A model of autoimmune hepatitisCentrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation.Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitisEvaluation of the role of HLA-DR antigens in Japanese type 1 autoimmune hepatitis.Wilson's Disease in Bangladeshi Children: Analysis of 100 Cases
P2860
Q24240280-D9481DB6-901E-4AD4-906D-92FED2550777Q26746242-CBC3C106-29C8-44AA-B9CD-5B351486C14BQ26991971-D6FC45AD-8A18-4524-90C8-A2BE632F80D0Q28480548-6F455BE8-52BE-40C3-A73D-6F4AC711238AQ29619682-B2E7C292-5544-47A1-B26D-C762BA6538F9Q30368738-7CA780B9-59A3-4DBB-B43D-A84480C2F9B2Q33371491-6687D8FD-07A1-421B-BADD-C92461D7E135Q33390083-BFD92F56-9866-49C5-B441-9393833A44A0Q33402513-6CC83570-1E2B-4BA8-9740-8E0594EEFA1BQ33447479-5BCF6ABB-A7F5-459B-AF2D-CE8634EF9D12Q33547476-E82C413D-7457-407A-BA29-22ACA4C96121Q33565469-3CD1029D-AD1C-417B-AC3F-2001E2C8EC21Q33595446-A03988B7-33B7-4314-90EC-8B8891558ED1Q33687100-E6CAA099-3BA4-4DD9-97EA-139BDF70221BQ33688293-F1F9A718-E6A9-448B-87C8-C4CD5D5B3B3CQ33780213-1A2C801C-B3F6-4152-AEDD-FB34977DC635Q33829963-5A53BF58-877F-4250-9428-BC4D1C310B5BQ33868452-D23E2980-8B64-427F-B292-40BA1F429631Q33869556-D324089C-F9E9-4196-B941-A3EF377A2BD0Q33883569-0DC91317-B7BB-4617-B190-7377F9BE0581Q34100094-E2F13CFE-12CF-4286-8B92-6BD974881B2EQ34149523-EFBFE999-A390-40FC-AA24-18081934C4A7Q34153004-D04B10CB-5F31-4785-BE14-51194EED1B93Q34236096-0BAE0B4A-8FF5-438B-B558-A51A9A62B0A6Q34369116-9F842898-5344-4F35-B899-E15A20F55B5CQ34408950-5A996374-8271-41FE-847D-EBFF5172B224Q34469059-602B7653-E641-448A-AE6B-78D163202E6BQ34514665-710F308E-A92C-45A8-9EE2-EA5143CBFE35Q34522550-E843E1A4-D7D0-4644-8E43-C9C7C2DE8050Q34537197-B64B7952-51AF-45A7-B326-60AB059C4461Q35066577-F5879681-085E-46E1-98E6-42B0A60EB726Q35126088-F2934CBB-E742-4C5C-80FE-C686600BD8DCQ35230369-AF4A4C24-89D9-4029-BDED-DAC742AD8413Q35588517-E769B342-846B-4FBB-AD2F-31B1E0B071E2Q35642787-E5DB7DAB-A23B-4985-85EB-EC8566E85AE6Q35670435-4DD46A2E-DCAC-4BFC-B91F-07C971FB44EEQ35769798-692E6F2D-910C-45C0-A637-805EDD68B22DQ35769853-8AC71ED9-D7E4-4CD2-949B-FC8DD5CE8355Q35816428-6BD6B525-048D-4945-BD03-556406914279Q35823693-9164848B-5C00-47CD-B970-54C82ADA23D0
P2860
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Diagnosis and treatment of autoimmune hepatitis.
@en
type
label
Diagnosis and treatment of autoimmune hepatitis.
@en
prefLabel
Diagnosis and treatment of autoimmune hepatitis.
@en
P2093
P356
P1433
P1476
Diagnosis and treatment of autoimmune hepatitis.
@en
P2093
Albert J Czaja
American Association for the Study of Liver Disease
Deborah K Freese
P304
P356
10.1053/JHEP.2002.34944
P407
P577
2002-08-01T00:00:00Z